fbpx European Innovation - Challenge | JLABS
European Innovation

European Innovation

Challenge ended

€100,000 in grant funds

Global Public Health



AlphaBiomics develops microbiome-based precision medicine solutions to predict drug response and improve drug therapy. By deciphering how gut microbiome influences individual responses to medicines, AlphaBiomics predicts how well individuals will respond to particular therapies and designs companion therapeutics to boost patient response to their medicines. AlphaBiomics will employ their platform to deliver safer and more efficacious immunotherapy in autoimmune diseases.

The Challenge

Image paragraph

The European Pharmaceutical Market is projected to grow from €169 Billion in 2015 to €206 Billion in 2022. (source). One of the 20th century's most innovative pharmaceutical researchers -  Dr. Paul Janssen -  first established Janssen Pharmaceutica N.V. in Europe more than six decades ago and lay the foundation for the discovery and development of more than 80 new medicines. That Belgian biotech industry alone funneled €3.4 billion into research and development in 2016, a staggering increase of 123% compared to 10 years earlier.

In celebration of and collaboration with these strides in human healthcare, Johnson & Johnson Innovation Limited and Johnson & Johnson Innovation, JLABS have launched the European Innovation QuickFire Challenge. The innovator with the best idea, technology, or solution that improves human healthcare and impacts the European ecosystem will receive up to €100,000 in grants as well as a voucher for one year of residency at an available JLABS locations, including a laboratory bench, workstation and access to the global JLABS community. 

JLABS is continuing to expand towards a truly global open innovation ecosystem by nurturing breakthrough science at a growing network of JLABS locations, including upcoming launches spanning from New York City to Shanghai. This unique model provides entrepreneurs with access to state-of-the-art infrastructure, expertise, and funding opportunities in a no-strings-attached environment.

Rewards and benefits

€100,000 in grant funds
  • 1 year residency at an available JLABS locations
  • Access to the global JLABS network

Areas of Interest

We encourage applications from companies working on all aspects of human healthcare, and have a particular interest in the following areas:

  • Pharmaceuticals
  • Consumer products
  • Medical devices
  • Global public health
  • Health technologies
  • Cross sector initiatives

Why this challenge matters to us:

At Johnson & Johnson Innovation, we believe a good idea can come from anywhere, and it's our goal to find new and innovative technologies that provide solutions to patients from across the world. Working together, we can spark the next great idea that will change the trajectory of health.

Frequently Asked Questions

What if I'm having trouble accessing the portal/website?

Make sure your browser is up to date and accepting cookies. You can contact customer service at https://jnjawards.fluidreview.com/helpdesk/contact/ if you are having technical difficulties as well.

For awards involving residency at JLABS, what does that entail and for how many people?

For challenges involving residency at JLABS, that entails 1 lab bench and 1 workstation (desk) for 2 people maximum. If you have more employees, we can rent out an additional residency.

For prizes involving residency at JLABS, are there any expenses not covered by JLABS?

Each applicant will be required to submit to a background check, which is subject to a minimal fee.  We also collect a deposit that is refundable at the end of the lease term. There may be other expenses, but this will be dependent on the work that the company is doing in JLABS.  There may also be fees associated with EH&S waste, specialty equipment, printing and phone calls.

Will JLABS pay for my living costs, relocation or visas?

No, any additional fees and paperwork are up to the winner.

Can I submit supporting documents (for example a video) as part of my application?

You will have the opportunity and are encouraged to upload supporting materials such as slide decks, research papers, and videos as part of your application. You may submit a video along with your typed responses. Maximum length is 2 minutes.

Is it ok if some of the information I submit is confidential?

Do not submit confidential information. Only non-confidential information should be submitted and anything you submit will be treated as non-confidential.

What happens with IP (Intellectual Property)?

As this is a no strings attached arrangement, JLABS does not acquire any IP.  Any IP creation and/or protection remains the sole responsibility of the inventors.

Is a patent required to apply?

No, a patent is not required to apply.  However, you should not submit any information that you wish to keep confidential or that may negatively impact upon the future patentability of your invention.

What kind of science / technology is appropriate for the Challenges?

We encourage all to apply. Find out more about what areas we desire to explore here: https://www.jnjinnovation.com/partnering

Who is eligible to apply?

Each Challenge has its own terms & conditions that can be found prior to filling out the application.

What are the specific criteria for application?

Solutions will be evaluated by a panel of reviewers and judges on their ability to meet the following criteria:

  • Potential impact
  • Uniqueness of solution & level of competition in current market
  • Quality & feasibility of technology
  • Team credibility & capabilities
  • Plans for utilizing JLABS residency
  • Idea submission outlines interest in the innovation ecosystem in Europe
Who can I contact if I have questions about the Challenges or the application process?

Please contact [email protected] with any questions.

Where do I apply? And do I have to complete the application in one sitting?

You can setup an account at http:// jnjawards.fluidreview.com. You are able to save your work and log back in to finish at a later time if needed.

Application Process:

Solutions will be evaluated by a panel of reviewers and judges on their ability to meet the following criteria:

  • Potential impact
  • Uniqueness of solution & level of competition in current market
  • Quality & feasibility of technology
  • Team credibility & capabilities
  • Plans for utilizing JLABS residency
  • Idea submission outlines interest in the innovation ecosystem in Europe


Applications open at BIO-Europe Launch
Midnight PDT | Submission deadline
Reviewers scoring period
Judging process begins
Finalist presentations (judging panel selects challenge winner(s))
Winner announcement in Q4 2018

Apply Now

Submit your idea today!

Don’t miss the deadline

About Johnson & Johnson Innovation, JLABS

Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow.  At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries.  JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property.  JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and digital health sectors.

JLABS currently has locations in innovation hot spots across the world and produces entrepreneurial programs and campaigns to seek out the best science, like the QuickFire Challenges around the globe. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then, has established two locations in San Francisco - one through a collaboration with the California Institute for Quantitative Biosciences (QB3) and a second standalone facility in South San Francisco.  JLABS is also located in Boston through a collaboration with LabCentral, in Lowell, Massachusetts through a collaboration with UMass, in Houston through a collaboration with the Texas Medical Center (TMC), in Toronto through a collaboration with the Ontario Government and the University of Toronto. .For more information about JLABS, please visit www.jlabs.jnjinnovation.com.

About Johnson & Johnson Innovation

Johnson & Johnson Innovation Limited focuses on accelerating early-stage innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers, Johnson & Johnson Innovation | JLABS, Johnson & Johnson Innovation – JJDC, Inc. and our Business Development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. For more information, visit www.jnjinnovation.com or follow @JNJInnovation